Asthma Exacerbations
12
4
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
25%
3 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Blood Eosinophil Guided Versus Usual Care In The Management Of Mild To Moderate Asthma at Primary Care (BEAM)
Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation
Bronchial Thermoplasty for Adults With Severe Asthma in the Biologic Era
Individualizing Treatment for Asthma in Primary Care (Full Study)
Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
Nursing Interventions to Mitigate Climate Change-related Effects on Symptom Severity and Physical Capacity
Vitamin D In the Prevention of Viral-induced Asthma in Preschoolers
Reusable Face Masks to Reduce Risk of Viral Respiratory Infections and Asthma Exacerbations
DOSE Trial: Optimal Dose of Oral Corticosteroids to Treat Asthma Exacerbations
Study on Effect of Papworth Technique in Anemic Asthmatic Pediatrics
A Cohort Study of Risk Factors and Prognosis for Frequent Acute Asthma Exacerbations Phenotype
Probiotics and Infections in Conscripts in Military Service